# Platelet-rich plasma-derived microRNA let-7a-5p alleviates knee osteoarthritis by regulating macrophage polarization and improving inflammatory microenvironment

**Authors:** Qishan Li, Mengjie Wang, Dong Wang, Yaochi Nie, Xueyuan Sun, Lin Na, Dongmei Yan, Yuhang Ma, Hui Wang

PMC · DOI: 10.3389/fimmu.2026.1756467 · Frontiers in Immunology · 2026-02-16

## TL;DR

This study shows that a specific microRNA in platelet-rich plasma helps reduce knee osteoarthritis by changing immune cell behavior and reducing inflammation.

## Contribution

The study identifies let-7a-5p as a novel therapeutic microRNA in PRP that regulates macrophage polarization and inflammation in knee osteoarthritis.

## Key findings

- PRP inhibits M1 macrophage polarization and promotes M2 polarization, reducing inflammation and cartilage damage.
- MicroRNA let-7a-5p was identified as a key regulator of macrophage polarization and cartilage degeneration in KOA.
- MAPK8 was experimentally validated as a direct target of let-7a-5p, linking it to the therapeutic effects of PRP.

## Abstract

Knee osteoarthritis (KOA) is closely associated with an imbalance in macrophage M1/M2 polarization within its inflammatory microenvironment. Platelet-rich plasma (PRP) has demonstrated therapeutic efficacy in KOA. Moreover, microRNAs (miRNAs) also play a protective or destructive role in the pathogenesis of KOA. This study aims to elucidate the molecular mechanisms by which PRP-related miRNAs ameliorate the inflammatory microenvironment to alleviate KOA.

An in vivo KOA rat model was established via intra-articular injection with monosodium iodoacetate (MIA). Safranin O-fast green staining and hematoxylin and eosin (HE) staining were used to assess cartilage degeneration and synovial inflammation, respectively. Macrophage phenotype was analyzed by immunohistochemistry (IHC) and immunofluorescence (IF). Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to examine the expression of inflammatory cytokines. Chondrocyte anabolic and catabolic status was evaluated using IF and western blotting (WB). Bioinformatics analysis was employed to screen for differentially expressed miRNAs in PRP and Dual-luciferase reporter assay was conducted to verify that mRNA is a direct target for miRNA. Furthermore, we explored the biological functions of miRNA and mRNA by transfecting mimics and siRNA.

In vitro, PRP inhibited M1-type macrophage polarization while promoting M2-type polarization, leading to suppressed pro-inflammatory cytokine release and enhanced anti-inflammatory cytokine release, collectively reducing cartilage degeneration. We identified microRNA let-7a-5p using bioinformatic approaches and subsequently investigated its molecular mechanisms. Similar to PRP, let-7a-5p was found to regulate macrophage polarization, the release of inflammatory cytokine, and cartilage degeneration. Furthermore, we identified and experimentally validated MAPK8 as a target gene of let-7a-5p.

PRP reshapes macrophage polarization by regulating the let-7a-5p/MAPK8 axis, thereby improving the inflammatory microenvironment of KOA and providing a potential new therapeutic target for KOA management.

## Linked entities

- **Genes:** MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599]
- **Chemicals:** monosodium iodoacetate (PubChem CID 5239)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tlr2 (toll-like receptor 2) [NCBI Gene 310553], Mmp13 (matrix metallopeptidase 13) [NCBI Gene 171052], Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Mir145a (microRNA 145a) [NCBI Gene 387163] {aka Mir145, Mirn145, mir-145a, mmu-mir-145, mmu-mir-145a}, Tgfb3 (transforming growth factor, beta 3) [NCBI Gene 25717] {aka TGF-B3}, Fpr1 (formyl peptide receptor 1) [NCBI Gene 292409], Acan (aggrecan) [NCBI Gene 58968] {aka Agc, Agc1}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 116554] {aka JNK}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Mmut (methylmalonyl-CoA mutase) [NCBI Gene 688517] {aka Mut}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Prp2l1 (proline rich protein 2-like 1) [NCBI Gene 287750] {aka PRP, PRP-2, Prp-5, Prp2l2}
- **Diseases:** restricted mobility (MESH:D014086), Synovitis (MESH:D013585), KOA (MESH:D020370), joint (MESH:D007592), joint stiffness (MESH:C535724), inflammatory cytokine (MESH:D000080424), Chondrocyte degeneration (MESH:D009410), MIA (MESH:C562377), pulmonary fibrosis (MESH:D011658), dislocation (MESH:D004204), functional impairment (MESH:D003072), disability (MESH:D009069), degenerative joint disease (MESH:D019636), Synovial inflammation (MESH:D007249), pain (MESH:D010146), lung tissue damage (MESH:D055370), obesity (MESH:D009765), OA (MESH:D010003), wear (MESH:D057085), Cartilage degeneration (MESH:D002357), cervical (MESH:D002575)
- **Chemicals:** Biofroxx 1139 (-), Safranin O (MESH:C009195), sodium citrate (MESH:D000077559), penicillin (MESH:D010406), hematoxylin (MESH:D006416), L-glutamine (MESH:D005973), LPS (MESH:D008070), paraformaldehyde (MESH:C003043), eosin (MESH:D004801), PVDF (MESH:C024865), DAPI (MESH:C007293), paraffin (MESH:D010232), EDTA (MESH:D004492), calcium gluconate (MESH:D002125), F-12 (MESH:C007782), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), pentobarbital sodium (MESH:D010424), MIA (MESH:D019807), TRIzol (MESH:C411644), SDS (MESH:D012967)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** NR8383 — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_4396), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950549/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950549/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950549/full.md

---
Source: https://tomesphere.com/paper/PMC12950549